臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :2825920
	造訪人次 : 31406301 線上人數 : 838 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"i chin"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 1-10 / 16 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國立成功大學	2023-12	Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy	Wang;Chrong-Reen;Tsai;Hung-Wen;Wu;I-Chin
國立成功大學	2023-11	Autoimmune hepatitis and primary biliary cholangitis overlap disease in a systemic lupus erythematosus patient receiving long-term B-cell depletion therapy	Wang;Chrong-Reen;Tsai;Hung-Wen;Wu;I-Chin
國立成功大學	2023-04-29	Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan	Wu;Juei-Seng;Lin;Yih-Jyh;Chang;Ting-Tsung;Wang;Chung-Teng;Liu;Wen-Chun;Hsieh;Ming-Tsung;Wu;I-Chin;Chen;Po-Jun;Chen;Chiung-Yu;Lin;Sheng-Hsiang;Chuang;Chiao-Hsiung;Han;Meng-Zhi;Chen;Huang-Pin;Tsai;Hong-Ming;Kuo;Hsin-Yu
國立成功大學	2023-02	Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma	Chiang;Hsueh-Chien;Lee;Yang-Cheng;Chang;Ting-Tsung;Lin;Yih-Jyh;Wu;Hung-Tsung;Wang;Chung-Teng;Chen;Chiung-Yu;Chen;Po-Jun;Hsieh;Ming-Tsung;Lin;Sheng-Hsiang;Chen;Shang-Hung;Chuang;Chiao-Hsiung;Wu;I-Chin;Hong;Tzu-Chun;Wu;Juei-Seng;Han;Meng-Zhi;Chen;Wei-Ting;Chiang;Chien-Ming;Hung;Kuan-Kai;Kuo;Hsin-Yu
國立成功大學	2022-11	Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma	Kuo;Hsin-Yu;Han;Meng-Zhi;Liao;Chih-Hsiang;Lin;Yih-Jyh;Wang;Chung-Teng;Chen;Shang-Hung;Chang;Ting-Tsung;Chen;Po-Jun;Lin;Sheng-Hsiang;Chen;Chiung-Yu;Chuang;Chiao-Hsiung;Wu;I-Chin;Wu;Juei-Seng;Hong;Tzu-Chun;Hsieh;Ming-Tsung;Lee;Yang-Cheng;Wu;Hung-Tsung;Tsai;Hong-Ming
國立成功大學	2021-07	Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis	Tsai;Hong-Ming;Han;Meng-Zhi;Lin;Yih-Jyh;Chang;Ting-Tsung;Chen;Chiung-Yu;Cheng;Pin-Nan;Chuang;Chiao-Hsiung;Wu;I-Chin;Chen;Po-Jun;Kang;Jui-Wen;Chiu;Yen-Cheng;Chiu;Hung-Chih;Chien;Shih-Chieh;Kuo;Hsin-Yu
國立成功大學	2021-06	Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss	Wu;I-Chin;Liu;Wen-Chun;Chiu;Yen-Cheng;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung
國立成功大學	2021-03	Effectiveness and safety of ledipasvir/ sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan	Chiu;Hung-Chih;Chiu;Yen-Cheng;Yang;Er-Hsiang;Chang;Ting-Tsung;Chien;Shih-Chieh;Wu;I-Chin;Wu;Chun-Hsien;Cheng;Pin-Nan
國立成功大學	2020-05	Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma	Kuo;Hsin-Yu;Chiang;Nai-Jung;Chuang;Chiao-Hsiung;Chen;Chiung-Yu;Wu;I-Chin;Chang;Ting-Tsung;Tsai;Hong-Ming;Lin;Yih-Jyh
國立成功大學	2020-04	Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients	Liu;Wen-Chun;Wu;I-Chin;Chiu;Yen-Cheng;Tseng;Kuo-Chih;Chen;Chi-Yi;Chiu;Hung-Chih;Cheng;Pin-Nan;Chang;Ting-Tsung

顯示項目 1-10 / 16 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目